True, I agree. But the fact is we have SEC filings for a transparent penny company explaining the recent influx of shares. We have definitive statements from filings that the company will need working capital to drive more revenue. We have the possibility of large contracts hanging out there. This is definitely not your typical penny dilution machine, and you can't deny that. There are no paid promotional web sites "picking MCLN" in return for equities. You may be able to argue BioMed was paid, but there has been ZERO disclosure of that -- unless of course you or anyone else can link it.
Lastly, to the NSS situation, it's a fact it's on the REG SHO list and is an imminent buy in. So putting all those together, it's not an excuse but rather a fact that has to be put into consideration of all the rest of the facts.
